What is Neurocrine Biosciences's other income (expense)?

Neurocrine Biosciences (NBIX) reported other income (expense) of $53.4M in Q1 2026.

How has Neurocrine Biosciences's other income (expense) changed year-over-year?

Neurocrine Biosciences's other income (expense) increased by 700.0% year-over-year, from -$8.9M to $53.4M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Neurocrine Biosciences NBIX Other Income (Expense)

Other Income (Expense) at other companies

Bristol-Myers SquibbBMY

$61M+112%

Acadia PharmaceuticalsACAD

$542K-7.8%

Crinetics PharmaceuticalsCRNX

$12.53M-14.3%

Solid Biosciences Inc.SLDB

$571K-25.8%

MapLight Therapeutics, Inc. MPLT

$1.36M+248%

BridgeBio PharmaBBIO

-$60.6M+7.1%

Other financials

Income statement

See full

Revenue$814.5M+42.2%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$18.38B+38.4%

Enterprise value$18.57B+37.6%

P/E27.5×-10.6×

P/S5.9×+0.6×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's other income (expense)?: Neurocrine Biosciences (NBIX) reported other income (expense) of $53.4M in Q1 2026.
How has Neurocrine Biosciences's other income (expense) changed year-over-year?: Neurocrine Biosciences's other income (expense) increased by 700.0% year-over-year, from -$8.9M to $53.4M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.